In humans, the embryonic liver is formed from endodermal cells of the ventral foregut, 24–26 days post-conception [
1Embryology of the liver and intrahepatic biliary tract, and an overview of malformations of the bile duct.
,
2Liver specification and early morphogenesis.
]. Endodermal cells grow out and form a bud, the hepatic diverticulum, that gives rise to the parenchyma (hepatocytes) and bile duct system (biliary epithelial cells). The hepatic diverticulum grows into the mesenchymal framework of the septum transversum. Within the septum transversum, spaces appear that will be surrounded by flat, evenly aligned, mesodermal cells, which resemble endothelial cells in the capillaries or sinusoids. The endodermal sprouts from the diverticulum (the hepatoblasts) will extend between the endothelium-lined spaces, thus establishing the basic composition of liver tissue: cords of epithelial cells, separated by sinusoidal vessels. These developments are well underway by the 32nd day of human embryonic development. By using SE-1 monoclonal antibody to label sinusoidal endothelial cells and Factor VIII antibodies to mark endothelial cells of the larger veins, Morita and colleagues have provided experimental support that sinusoidal endothelial cells do not derive from ingrowing vitelline veins [
[3]- Morita M.
- Qun W.
- Watanabe H.
- Doi Y.
- Mori M.
- Enomoto K.
Analysis of the sinusoidal endothelial cell organization during the developmental stage of the fetal rat liver using a sinusoidal endothelial cell specific antibody, SE-1.
].
Active macrophages (Kupffer cells) and stellate cells become identifiable during the second half of the third month (75–90th day) of human development [
]. These early Kupffer cells may derive from primitive macrophages which are first present in the yolk sac and colonize the liver [
[5]- Naito M.
- Takahashi K.
- Ohno H.
- Nishikawa S.
Yolk-sac macrophages-a possible Kupffer cell precursor in fetal mouse liver.
]. In adult life, the early macrophages coexist with macrophages from extrahepatic sources [
[6]- Bouwens L.
- Knook D.L.
- Wisse E.
Local proliferation and extrahepatic recruitment of liver macrophages (Kupffer cells) in partial-body irradiated rats.
]. Stellate cells also appear in the second half of the third month of human embryonic development. They are located in the space of Disse and contain 1–2 lipid droplets. In the 5-month human fetus, stellate cells contain small lipid droplets [
[7]Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A—storing cells in extrahepatic organs.
]. At birth, stellate cells have not reached their final shape and size [
[8]- Wake K.
- Motomatsu K.
- Ekataksin W.
Postnatal development of the perisinusoidal stellate cells.
]. In the 1-day neonatal rat, stellate cells are rather rounded with slim and scanty processes. Two to three weeks after birth, the cell processes extend with the formation of perforated membranous appendages. Five weeks after birth, rat stellate cells have reached their definitive dendritic configuration with elongated perisinusoidal and thicker intersinusoidal extensions.
Hepatic stellate cells represent 5–8% of all human liver cells and 13% of the volume of sinusoidal cells. They have long cytoplasmic processes which run parallel to the sinusoidal endothelial wall. Second order branches sprout out from the processes, embrace the sinusoid and penetrate between hepatocytes reaching neighbouring sinusoids. Some stellate cells are in close contact with nerve endings. In normal liver, stellate cells are mainly involved in storage of vitamin A. In addition, they synthesize extracellular matrix molecules, matrix degrading metalloproteinases, cytokines and growth factors. Following acute or chronic liver injury, stellate cells get activated. They undergo a process of transdifferentiation leading to a myofibroblastic phenotype. Activated stellate cells are characterized by the loss of vitamin A-rich lipid droplets, increased proliferation, enhanced contractile properties, release of pro-infammatory, pro-fibrogenic and pro-mitogenic cytokines, migration to sites of injury, increased secretion of extracellular matrix, and altered matrix proteinase activity providing the fundamental requirements for tissue repair. In acute or self-limited liver damage, these changes are transient whereas in the case of persistent injury, they lead to chronic inflammation and enhanced deposition of extracellular matrix leading to fibrosis and cirrhosis. In addition, stellate cells are involved in the pathogenesis of portal hypertension [
[9]- Reynaert H.
- Thompson M.G.
- Thomas T.
- Geerts A.
Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.
], and in progression of primary or metastatic liver cancer [
[10]- Olaso E.
- Santisteban A.
- Bidaurrazaga J.
- Gressner A.M.
- Rosenbaum J.
- Vidal-Vanaclocha F.
Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis.
].
The embryonic origin of stellate cells is as yet unresolved with some studies favouring a mesenchymal [
[11]- Enzan H.
- Himeno H.
- Hiroi M.
- Kiyoku H.
- Saibara T.
- Onishi S.
Development of hepatic sinusoidal structure with special reference to the Ito cells.
], some others an endodermal [
12- Kiassov A.P.
- Van Eyken P.
- van Pelt J.F.
- Depla E.
- Fevery J.
- Desmet V.J.
- Yap S.H.
Desmin expressing nonhematopoietic liver cells during rat liver development: an immunohistochemical and morphometric study.
,
13- Vassy J.
- Rigaut J.P.
- Briane D.
- Kraemer M.
Confocal microscopy immunofluorescence localization of desmin and other intermediate filament proteins in fetal rat livers.
] and yet others a neuro-ectodermal origin [
14- Niki T.
- Pekny M.
- Hellemans K.
- Bleser P.D.
- Berg K.V.
- Vaeyens F.
- Quartier E.
- et al.
Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells.
,
15Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research.
,
16Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.
].
The view that stellate cells are of mesenchymal origin is largely based on electron microscopic studies of the embryonic human and rodent liver [
[11]- Enzan H.
- Himeno H.
- Hiroi M.
- Kiyoku H.
- Saibara T.
- Onishi S.
Development of hepatic sinusoidal structure with special reference to the Ito cells.
], and on the fact that stellate cells express vimentin [
17- Schmitt-Graff A.
- Kruger S.
- Bochard F.
- Gabbiani G.
- Denk H.
Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers.
,
18- Hautekeete M.L.
- Geerts A.
The hepatic stellate (Ito) cell: its role in human liver disease.
]. Transmission electron microscopy shows that when the liver primordium grows into the mesenchymal tissue of the septum transversum, ‘mesenchymal’ cells with myofibroblastic morphology get trapped between the ingrowing hepatoblasts and sinusoidal endothelium. The ‘trapped’ cells develop subsequently lipid droplets and are therefore interpreted as precursors of mature stellate cells. The mesenchymal nature of the ‘trapped’ cells is based on morphological similarities between the latter and the cells present in the septum transversum. Other studies have shown that rodent and human stellate cells express vimentin [
17- Schmitt-Graff A.
- Kruger S.
- Bochard F.
- Gabbiani G.
- Denk H.
Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers.
,
18- Hautekeete M.L.
- Geerts A.
The hepatic stellate (Ito) cell: its role in human liver disease.
]. This observation supports but does not prove the mesenchymal origin of stellate cells. The literature contains numerous examples of epithelial–mesenchymal transition characterized by loss of expression of keratins in favour of expression of vimentin, or vice-versa [
[19]- Okada H.
- Inoue T.
- Suzuki H.
- Strutz F.
- Neilson E.
Epithelial–mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo.
].
Two groups have reported that around day 12–13 of rat embryonic development, some non-hematopoietic liver cells are stellate-shaped and co-express cytokeratins 8 and 18 (hepatoblast markers) and desmin (stellate cell marker). This co-expression ceases to exist as from day 18 [
20- Vassy J.
- Rigaut J.P.
- Briane D.
- Kraemer M.
Confocal microscopy immunofluorescence localization of desmin and other intermediate filament proteins in fetal rat livers.
,
21- Kiassov A.P.
- Van Eyken P.
- van Pelt J.F.
- Depla E.
- Fevery J.
- Desmet V.J.
- Yap S.H.
Desmin expressing nonhematopoietic liver cells during rat liver development: an immunohistochemical and morphometric study.
]. This data suggests that hepatocytes and stellate cells may derive from a common endodermal precursor. In early embryonic mouse liver, however, such common precursor cells have not been confirmed [
[22]- Nitou M.
- Ishikawa K.
- Shiojiri N.
Immunohistochemical analysis of development of desmin-positive hepatic stellate cells in mouse liver.
].
Quiescent stellate cells contain a host of neural marker proteins: GFAP, nestin; the nerve growth factors NGF, BDGF, NT-3 and NT4/5; the nerve growth factor receptors p75, Trk-B, Trk-C; the cell adhesion protein N-CAM; the prion protein PrP
C and synaptophysin (for review, see [
[23]History, heterogeneity, developmental biology and functions of quiescent hepatic stellate cells.
]). Moreover, they display a dendritic morphology similar to astrocytes rather than to the spindle-shape of quiescent skin fibroblasts. These observations have led to the speculation that stellate cells could be of neuro-ectodermal origin [
24- Niki T.
- Pekny M.
- Hellemans K.
- Bleser P.D.
- Berg K.V.
- Vaeyens F.
- Quartier E.
- et al.
Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells.
,
25Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.
]. Embryonic neural tissues contain multipotent cells that can form different sublineages under the influence of growth factors. These multipotent cells will become glial cells when exposed to neuregulin isoform I, or neurons under the influence of BMP-2, or myofibroblasts/smooth muscle cells when incubated with TGF-β [
26- Hagedorn L.
- Suter U.
- Sommer L.
P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors.
,
27- Morrison S.J.
- White P.M.
- Zock C.
- Anderson D.J.
Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells.
].
In this issue of the Journal, Baba and colleagues [
[28]Baba S, Fujii H, Hirose T, Yasuchika K, Azuma H, Hoppo T, et al. Commitment of bone marrow cells to hepatic stellate cells in mouse. J Hepatol 2004;40:255--260.
] as well as Suskind and Muench [
[29]Suskind DL, Muench MO. Searching for common stem cells of the hepatic and hematopoietic systems in the human fetal liver: CD34+ cytokeratin 7/8+ cells express markers for stellate cells. J Hepatol 2004;40:261--268.
], report new data that shed a different light on the origin of stellate cells. Baba and colleagues use bone marrow of green fluorescent protein (GFP) transgenic mice which is administered to age-matched C57BL/J mice. Subsequently, hepatic stellate cells are isolated from the livers of the recipient mice. GFP-expressing cells with intracytoplasmic lipid droplets comprise 33.4% of the total number of isolated cells. The GFP expressing cells also contain stellate cell lineage markers such as desmin, GFAP and α-SMA. The authors conclude that bone marrow is a source of stellate cell precursor cells.
In the light of the controversy that has arisen about the recruitment of hepatocytes from bone marrow precursor cells, the data generated by Baba et al. should be interpreteted with caution. Initial reports claimed recruitment of new hepatocytes from extrahepatic precursor cells such as bone marrow stem cells [
30- Petersen B.E.
- Bowen W.C.
- Patrene K.D.
- Mars W.M.
- Sullivan A.K.
- Murase N.
- Boggs S.S.
- et al.
Bone marrow as a potential source of hepatic oval cells.
,
31- Lagasse E.
- Connors H.
- Al-Dhalimy M.
- Reitsma M.
- Dohse M.
- Osborne L.
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.
,
32- Theise N.D.
- Nimmakayalu M.
- Gardner R.
- Illei P.B.
- Morgan G.
- Teperman L.
- Henegariu O.
- et al.
Liver from bone marrow in humans.
]. However, initial enthusiasm has been dampened by several studies that showed cell fusion of extrahepatic precursor cells with pre-existing hepatocytes [
33- Wang X.
- Willenbring H.
- Akkari Y.
- Torimaru Y.
- Foster M.
- Al-Dhalimy M.
Cell fusion is the principal source of bone-marrow derived hepatocytes.
,
34- Terada N.
- Hamazaki T.
- Oka M.
- Hoki M.
- Mastalerz D.
- Nakano Y.
Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion.
,
35- Ying Q.L.
- Nichols J.
- Evans E.
- Smith A.
Changing potency by spontaneous fusion.
,
36- Vassilopoulos G.
- Wang P.
- Russell D.
Transpalnted bone marrow regenerates liver by fusion.
]. The resulting cells were aneuploid containing chromosomes from both recipient and donor, and had acquired hepatocytic differentiation markers as a result of merger rather than by differentiation of precursor cells into bona fide diploid hepatocytes.
In the light of the hepatocyte experience, the conclusions by Baba et al., although not unreasonable in themselves, should be followed up by experiments to exclude (i) that pre-existing desmin-positive or GFAP-positive liver cells from the recipient mice fuse with GFP expressing bone marrow cells from the donor mice, and (ii) that desmin-negative or GFAP-negative cells undergo unexpected transdifferentiation as a result of the experimental procedures, thereby expressing an abnormal set of intermediate filament proteins.
Suskind and Muench have examined by flow cytometry the question whether midgestational embryonic human liver contains a common precursor cell that gives rise to both resident liver cells and hematopoietic cells. Contrary to their initial hypothesis, the authors identified a population of CD34
+ cytokeratin (CK)7/8
+ precursor cells that were different in several aspects from CD34
+CK7/8
− haematopoietic precursor cells. CD34
+CK7/8
+ cells were positive for CD13, CD59, NGFR, desmin and α-SMA. In flow cytometry, their forward and side scatter were higher than those of CD34
+CK7/8
− cells indicating that the CD34
+CK7/8
+ cells were larger and had a more elaborate cytoplasm. In culture, CD34
+CK7/8
+ cells projected short cytoplasmic extensions. The authors conclude that CD34
+CK7/8
+ cells are embryonic stellate cell precursors. One issue that should be addressed before this conclusion can be accepted is why 94% of CD34
+CK7/8
+ cells is desmin-positive. Several previous immunohistochemical studies have shown that human stellate cells are desmin-negative [
17- Schmitt-Graff A.
- Kruger S.
- Bochard F.
- Gabbiani G.
- Denk H.
Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers.
,
18- Hautekeete M.L.
- Geerts A.
The hepatic stellate (Ito) cell: its role in human liver disease.
]. The authors also conclude that CD34
+CK7/8
+ cells form a lineage which is distinct from the haematopoietic lineage. Moreover, these data reinforce the view, but do not definitively prove, that stellate cells derive from endodermal precursor cells. Alternative interpretations of the presented data may be that a precursor cell common to CD34
+CK7/8
+ and CD34
+CK7/8
− cells exists in early embryonic development, but that this common precursor has disappeared by midgestation, or that CD34
+CK7/8
− cells evolve into CD34
+CK7/8
+ cells by means of transdifferentiation whereby cells become larger and express a different set of intermediate filament proteins. Furthermore, future studies should address the question in which micro-anatomical position CD34
+CK7/8
+ cells are located, and how these cells relate to ‘oval cells’. The latter cells have been reported to be positive for both CD34 [
37- Petersen B.E.
- Grossbard B.
- Hatch H.
- Pi J.
- Deng J.
- Scott E.
Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers.
,
38- Lazaro C.
- Croager E.
- Mitchell C.
- Campbell J.
- Foraker J.
- Rhim J.
- Yeoh G.
- et al.
Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes.
] and for CK7/8 [
[39]Hepatic progenitor cells in human liver diseases.
]. Therefore, the question arises whether hepatocytes, biliary epithelial cells and stellate cells derive from a common precursor cell?
The papers by Baba et al. and by Suskind and Muench, provide the Stellate Cell Community with new food for thought. Since 30 years, stellate cells are in the spotlights. Stellate cells play a prominent role in the pathogenesis of clinically important conditions such as hepatic fibrosis and cirrhosis, portal hypertension and liver cancer. Understanding the basic biology of stellate cells will contribute to our understanding of the pathogenesis of the above conditions. Identification of the embryonic origin of stellate cells will improve our understanding of their relationship to other fibrogenic liver cells such as portal fibroblasts, periductular fibroblasts and ‘second layer cells’. It will also improve our insights into the relationship between hepatic and extrahepatic (pancreas, kidney, digestive canal, lung, spleen, adrenal, ductus deferens, uterus, vocal cords) stellate cells. Do all these stellate cells derive from the same precursor cells? Knowledge of the embryonic origin of stellate cells will also raise the possibility of using cell-lineage specific promoters to drive transgene expression selectively in stellate cells in vivo with a view of applying gene therapy. It will also open the prospect of reconstituting stellate cells from precursor cells in view of repopulating the liver with quiescent stellate cells in the event these cells have perished through apoptosis. Both Baba and colleagues, as well as Suskind and Muench, have brought these prospects closer to reality.
References
Embryology of the liver and intrahepatic biliary tract, and an overview of malformations of the bile duct.
in: McIntyre N. Benhamou J. Bircher J. Rizzetto M. Rodes J. Oxford textbook of clinical hepatology. Oxford University Press,
Oxford1991: 497-519Liver specification and early morphogenesis.
Mech Dev. 2000; 92: 83-88- Morita M.
- Qun W.
- Watanabe H.
- Doi Y.
- Mori M.
- Enomoto K.
Analysis of the sinusoidal endothelial cell organization during the developmental stage of the fetal rat liver using a sinusoidal endothelial cell specific antibody, SE-1.
Cell Struct Funct. 1998; 23: 341-348Digestive system.
in: Nishimura H. Atlas of human prenatal anatomy. Igaku-Shoin,
Tokyo1983: 171-234- Naito M.
- Takahashi K.
- Ohno H.
- Nishikawa S.
Yolk-sac macrophages-a possible Kupffer cell precursor in fetal mouse liver.
in: Wisse E. Knook D. Decker K. Cells of the hepatic sinusoid. Kupffer Cell Foundation,
Rijswijk1989: 419-420- Bouwens L.
- Knook D.L.
- Wisse E.
Local proliferation and extrahepatic recruitment of liver macrophages (Kupffer cells) in partial-body irradiated rats.
J Leukoc Biol. 1986; 39: 687-697Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A—storing cells in extrahepatic organs.
Int Rev Cytol. 1980; 66: 303-353- Wake K.
- Motomatsu K.
- Ekataksin W.
Postnatal development of the perisinusoidal stellate cells.
in: Wisse E. Knook D. McCuskey R. Cells of the hepatic sinusoid. Kupffer Cell Foundation,
Rijswijk1991: 269-275- Reynaert H.
- Thompson M.G.
- Thomas T.
- Geerts A.
Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.
Gut. 2002; 50: 571-581- Olaso E.
- Santisteban A.
- Bidaurrazaga J.
- Gressner A.M.
- Rosenbaum J.
- Vidal-Vanaclocha F.
Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis.
Hepatology. 1997; 26: 634-642- Enzan H.
- Himeno H.
- Hiroi M.
- Kiyoku H.
- Saibara T.
- Onishi S.
Development of hepatic sinusoidal structure with special reference to the Ito cells.
Microsc Res Tech. 1997; 39: 336-349- Kiassov A.P.
- Van Eyken P.
- van Pelt J.F.
- Depla E.
- Fevery J.
- Desmet V.J.
- Yap S.H.
Desmin expressing nonhematopoietic liver cells during rat liver development: an immunohistochemical and morphometric study.
Differentiation. 1995; 59: 253-258- Vassy J.
- Rigaut J.P.
- Briane D.
- Kraemer M.
Confocal microscopy immunofluorescence localization of desmin and other intermediate filament proteins in fetal rat livers.
Hepatology. 1993; 17: 293-300- Niki T.
- Pekny M.
- Hellemans K.
- Bleser P.D.
- Berg K.V.
- Vaeyens F.
- Quartier E.
- et al.
Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells.
Hepatology. 1999; 29: 520-527Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research.
J Hepatol. 2002; 37: 527Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.
J Biol Chem. 2000; 275: 2247-2250- Schmitt-Graff A.
- Kruger S.
- Bochard F.
- Gabbiani G.
- Denk H.
Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers.
Am J Pathol. 1991; 138: 1233-1242- Hautekeete M.L.
- Geerts A.
The hepatic stellate (Ito) cell: its role in human liver disease.
Virchows Arch. 1997; 430: 195-207- Okada H.
- Inoue T.
- Suzuki H.
- Strutz F.
- Neilson E.
Epithelial–mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo.
Nephrol Dial Transplant. 2003; 15: 44-46- Vassy J.
- Rigaut J.P.
- Briane D.
- Kraemer M.
Confocal microscopy immunofluorescence localization of desmin and other intermediate filament proteins in fetal rat livers.
Hepatology. 1993; 17: 293-300- Kiassov A.P.
- Van Eyken P.
- van Pelt J.F.
- Depla E.
- Fevery J.
- Desmet V.J.
- Yap S.H.
Desmin expressing nonhematopoietic liver cells during rat liver development: an immunohistochemical and morphometric study.
Differentiation. 1995; 59: 253-258- Nitou M.
- Ishikawa K.
- Shiojiri N.
Immunohistochemical analysis of development of desmin-positive hepatic stellate cells in mouse liver.
J Anat. 2000; 197: 635-646History, heterogeneity, developmental biology and functions of quiescent hepatic stellate cells.
Semin Liver Dis. 2001; 21: 311-335- Niki T.
- Pekny M.
- Hellemans K.
- Bleser P.D.
- Berg K.V.
- Vaeyens F.
- Quartier E.
- et al.
Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells.
Hepatology. 1999; 29: 520-527Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.
J Biol Chem. 2000; 275: 2247-2250- Hagedorn L.
- Suter U.
- Sommer L.
P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors.
Development. 1999; 126: 3781-3794- Morrison S.J.
- White P.M.
- Zock C.
- Anderson D.J.
Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells.
Cell. 1999; 96: 737-749Baba S, Fujii H, Hirose T, Yasuchika K, Azuma H, Hoppo T, et al. Commitment of bone marrow cells to hepatic stellate cells in mouse. J Hepatol 2004;40:255--260.
Suskind DL, Muench MO. Searching for common stem cells of the hepatic and hematopoietic systems in the human fetal liver: CD34+ cytokeratin 7/8+ cells express markers for stellate cells. J Hepatol 2004;40:261--268.
- Petersen B.E.
- Bowen W.C.
- Patrene K.D.
- Mars W.M.
- Sullivan A.K.
- Murase N.
- Boggs S.S.
- et al.
Bone marrow as a potential source of hepatic oval cells.
Science. 1999; 284: 1168-1170- Lagasse E.
- Connors H.
- Al-Dhalimy M.
- Reitsma M.
- Dohse M.
- Osborne L.
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.
Nat Med. 2000; 6: 1229-1234- Theise N.D.
- Nimmakayalu M.
- Gardner R.
- Illei P.B.
- Morgan G.
- Teperman L.
- Henegariu O.
- et al.
Liver from bone marrow in humans.
Hepatology. 2000; 32: 11-16- Wang X.
- Willenbring H.
- Akkari Y.
- Torimaru Y.
- Foster M.
- Al-Dhalimy M.
Cell fusion is the principal source of bone-marrow derived hepatocytes.
Nature. 2003; 422: 897-901- Terada N.
- Hamazaki T.
- Oka M.
- Hoki M.
- Mastalerz D.
- Nakano Y.
Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion.
Nature. 2002; 416: 542-545- Ying Q.L.
- Nichols J.
- Evans E.
- Smith A.
Changing potency by spontaneous fusion.
Nature. 2002; 416: 545-548- Vassilopoulos G.
- Wang P.
- Russell D.
Transpalnted bone marrow regenerates liver by fusion.
Nature. 2003; 422: 901-904- Petersen B.E.
- Grossbard B.
- Hatch H.
- Pi J.
- Deng J.
- Scott E.
Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers.
Hepatology. 2003; 37: 632-640- Lazaro C.
- Croager E.
- Mitchell C.
- Campbell J.
- Foraker J.
- Rhim J.
- Yeoh G.
- et al.
Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes.
Hepatology. 2003; 38: 1095-1106Hepatic progenitor cells in human liver diseases.
Semin Cell Dev Biol. 2003; 13: 389-396
Article info
Publication history
See Articles, pages 255–260 and 261–268
Copyright
© 2003 Published by Elsevier Inc.